相关实验视频
Updated: Jun 21, 2025
06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
7.7K
疾病修饰治疗的演变 对于Transthyretin心脏粉症
1National Amyloidosis Centre, University College London, Royal Free Campus, London, UK.
Heart international
|July 15, 2024
概括
心脏氨基粉症 (ATTR-CA) 的治疗方法正在进步. 像塔法米迪斯这样的新疗法稳定了跨甲状腺素,而基因沉默和抗粉样物质提供了对抗这种致命心肌病的新方法.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 晶氨酸心肌粉症 (ATTR-CA) 是一种由错误折叠的晶氨酸蛋白引起的渐进性致死性心肌病.
- 了解ATTR-CA的致病性刺激了针对疾病途径各个阶段的疾病修饰疗法的开发.
研究的目的:
- 审查当前和新兴的治疗策略,以治疗心脏粉症.
- 突出批准和正在研究的治疗方法的作用机制.
主要方法:
- 审查已批准的治疗方法,包括四相稳定剂 (Tafamidis,acoramidis).
- 讨论基因沉默剂 (帕蒂西兰,Vutrisiran,Eplontersen) 和基因编辑疗法 (NTLA-2001) 的讨论,这些疗法针对的是转基因胺素的产生.
- 探索旨在去除纤维的抗粉样蛋白疗法.
主要成果:
- 塔法米迪斯是目前唯一批准的ATTR-CA治疗方法,可以稳定四重聚合物.
- 基因沉默和基因编辑疗法旨在降低跨甲状腺素的合成.
- 抗粉样蛋白疗法正处于早期的研究阶段,有可能去除现有的粉样蛋白沉积物.
结论:
- 对于ATTR-CA,正在出现多种治疗策略,解决疾病的不同方面.
- 虽然塔法米迪斯已获得批准,但基因基因和抗粉样蛋白疗法具有未来的潜力,包括对晚期疾病的治疗.
- 这些进展解决了管理ATTR-CA的重大未满足的临床需求.
相关概念视频
01:22Alzheimer's Disease: Treatment
177
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
177
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K